Real world effectiveness of regorafenib in heavily pretreated patients with metastatic colorectal cancer.

被引：0
|
作者：
Danilova, Anastasia
Stroyakovsky, Daniil
Kanner, Dmitry
Chernikovksy, Ilya
Savelov, Nikita
Volkonsky, Mikhail
Demidova, Irina
机构：
[1] Moscow City Oncol Hosp 62, Krasnogorskiy Rayon, Russia
[2] Moscow City Oncol Hosp 62, Moscow, Russia
[3] Moscow City Oncol Hosp 62, Stepanovskoe, Russia
[4] SBIH Moscow City Oncol Hosp 62 DHM, Moscow, Russia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 3_SUPPL期
关键词：
298-11050; 283-237-255-11316; 261-492-199; 3282-206-4957-326-5009-5024-5025; 3282-206-4957-326-5009-2386; 613-135-244-3829-325; 10; 4; 3; 2; 250; 7; 38092-28187; 38092-25821; 38092-18849; 1;
D O I：
10.1200/JCO.2024.42.3_suppl.141
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：141 / 141
页数：1
相关论文
共 50 条
  • [31] Percutaneous liver venous deprivation: outcomes in heavily pretreated metastatic colorectal cancer patients
    Ghosn, Mario
    Kingham, T. Peter
    Ridouani, Fourat
    Santos, Ernesto
    Yarmohammadi, Hooman
    Boas, Franz E.
    Covey, Anne M.
    Brody, Lynn A.
    Jarnagin, William R.
    D'Angelica, Michael I.
    Kemeny, Nancy E.
    Solomon, Stephen B.
    Camacho, Juan C.
    HPB, 2022, 24 (03) : 404 - 412
  • [32] Eribulin in heavily pretreated metastatic breast cancer: A real-world data from India
    Mandal, T. K.
    Bajpai, J.
    Kapoor, A.
    Kumar, A.
    Ghosh, J.
    Gulia, S.
    Rath, S.
    Gupta, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S1264 - S1264
  • [33] A phase II trial of salvage treatment with gemcitabine and S-1 combination in heavily pretreated patients with metastatic colorectal cancer.
    Sym, Sun Jin
    Hong, Junshik
    Jung, Minkyu
    Park, Jinny
    Cho, Eun Kyung
    Lee, Jae Hoon
    Lee, Won-Suk
    Baek, Jeong-Heum
    Shin, Dong Bok
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [34] Real-world outcomes in metastatic colorectal patients receiving regorafenib treatment in China
    Qu, W.
    Jiang, Z.
    Liu, Z.
    Zhu, L.
    Chen, X.
    Liu, B.
    Zhao, Y.
    Li, S.
    Yan, H.
    Qu, X.
    Zang, A.
    Sun, Y.
    Zhou, A.
    ANNALS OF ONCOLOGY, 2022, 33 : S335 - S336
  • [35] Effectiveness, safety, and impact on quality of life of eribulin-based therapy in heavily pretreated patients with metastatic breast cancer: A real-world analysis
    Gui, Xinyu
    Liang, Xu
    Li, Huiping
    CANCER MEDICINE, 2023, 12 (16): : 16793 - 16804
  • [36] PROACTIVE ADVERSE EVENT MANAGEMENT IN REGORAFENIB-TREATED PATIENTS WITH METASTATIC COLORECTAL CANCER.
    Khoukaz, Taline
    Mitchell, Jessica
    ONCOLOGY NURSING FORUM, 2013, 40 (03) : E228 - E228
  • [37] Real-world safety and effectiveness of MVASI in metastatic colorectal cancer patients in Canada
    Cheung, Winson Y.
    Samimi, Setareh
    Ma, Kim
    Knight, Gregory John
    Kassam, Shaqil Nadirali
    Colwell, Bruce
    Beaudoin, Annie
    Vincent, Mark David
    Trinkaus, Mateya
    Filion, Alain
    Karachiwala, Hatim
    Asmis, Timothy
    Sideris, Lucas
    Nunez, Leyla
    Wani, Rajvi
    Morris, Carlye Cirone
    Ngan, Elaine
    Du, Yinhao
    Inam, Naila
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [38] Cost effectiveness of maintenance bevacizumab in patients with metastatic colorectal cancer.
    Lange, Joel
    Rajeev, Rahul
    Gamblin, T. Clark
    Turaga, Kiran
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [39] Comparative effectiveness of chemotherapy in elderly patients with metastatic colorectal cancer.
    Satram-Hoang, Sacha
    Ramanan, Devi
    Lee, Luen F.
    Yu, Shui
    Reyes, Carolina M.
    McKenna, Edward
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [40] Biweekly pegylated liposomal doxorubicin (Caelyx/Doxil) in heavily pretreated patients with metastatic breast cancer.
    Schmid, P
    Schulz, CO
    Dieing, A
    Lehenbauer-Dehm, S
    Flath, RA
    Sezer, O
    Possinger, K
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S204 - S204
12345